A Study to Evaluate ALN-4324 in Overweight to Obese Healthy Volunteers and in Overweight to Obese Patients With T2DM

NCT06845202 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

144

Enrollment

INDUSTRY

Sponsor class

Conditions

Obese or Overweight Healthy Volunteers
Type 2 Diabetes Mellitus (T2DM)

Interventions

DRUG: ALN-4324
DRUG: Placebo

Sponsor

Alnylam Pharmaceuticals